Ancalima Lifesciences Limited, a active public limited company, was established on 02 May 1988 in Sonipat, Haryana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U52110DL1988PLC031451. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹1.00 Cr.
Formerly known as Uni Sule Laboratories Pvt Ltd, Pfiscar India Limited. It upholds a compliant status. Employing 51 professional, Its leadership includes Sandeep Sharma (Director), Sakshi Garg (Director), Rajeev Garg (Director). Past directors included Sita Ram Garg, Sakshi Garg, Vishal Singla. It holds ₹4.66 Cr open charges and ₹16.78 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 50Th Km Stone,, National Highway No. 44, Murthal, Sonipat, Haryana, 131039.
U52110HR1988PLC135948
135948
02 May 1988
₹2.00 Cr
₹1.00 Cr
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Ancalima Lifesciences Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sandeep Sharma | Director | 01 Apr 2019 | Current |
| Sakshi Garg | Director | 01 Jul 2024 | Current |
| Rajeev Garg | Director | 15 Feb 1996 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Jul 2024 | Past |
| Pramod Abcsdd | Director | 01 Apr 2019 | Past |
| Pramod Abcsdd | Director | 02 Nov 2009 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Ancalima Lifesciences Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 3.38% decrease. The company also saw a substantial fall in profitability, with a 87.7% decrease in profit. The company's net worth dipped by a decrease of 0.2%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Ancalima Lifesciences had a promoter holding of 99.99% and a public holding of 0.01%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹46,575,000.00
₹167,823,508.50
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Feb 2025 | Others | ₹4.50 Cr | Open |
| 09 May 2024 | Canara Bank | ₹1.58 M | Open |
| 28 Sep 2022 | Canara Bank | ₹5.68 Cr | Satisfied |
| 01 Feb 2022 | Others | ₹3.17 M | Satisfied |
| 29 Sep 2020 | Others | ₹6.72 M | Satisfied |
Explore comprehensive loan charge details -
Ancalima Lifesciences has a workforce of 51 employees as of Aug 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Ancalima Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ancalima Lifesciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Others of Rs. 4.50 Cr registered on 04 Feb 2025 with Charge ID 101069934 was modified on 07 Mar 2025. was documented.
The activity A charge registered on 28 Sep 2022 via Charge ID 100620785 with Canara Bank was fully satisfied on 24 Feb 2025. was completed.
A charge with Others amounted to Rs. 4.50 Cr with Charge ID 101069934 was registered on 04 Feb 2025. was recorded as a recent event.
The activity Ancalima Lifesciences Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity Sakshi Garg was appointed as a Director was appointed as a Director on 01 Jul 2024 & has been associated with this company since 1 year 5 months . was completed.
The activity A charge with Canara Bank amounted to Rs. 0.16 Cr with Charge ID 100928220 was registered on 09 May 2024. was completed.
The CIN of Ancalima Lifesciences Limited is U52110HR1988PLC135948.
Ancalima Lifesciences Limited is headquartered at 50Th Km Stone,, National Highway No. 44, Murthal, Sonipat, Haryana, 131039.
Ancalima Lifesciences Limited was incorporated on 02 May 1988.
The current directors of Ancalima Lifesciences Limited are
The primary industry of Ancalima Lifesciences Limited is Manufacturing.
Ancalima Lifesciences Limited is unlisted.
The authorized capital of Ancalima Lifesciences Limited is ₹2.00 Cr, and the paid-up capital is ₹1.00 Cr.
The compliance status of Ancalima Lifesciences Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX